2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Saturday, April 29, 2017

5:30pm-7:30pm: Outcome of Adult Living Donor Renal Transplants in Different Era: Analysis of UNOS Database.

V. Whittaker, R. Gruessner, M. Laftavi, Z. Acun, A. Gruessner.

Poster Session A: Living Donor Kidney Transplant I • Hall D1

5:30pm-7:30pm: Outcome of Kidney Transplantation from Deceased Octogenarian Donors.

P. Donato, L. Furian, C. Silvestre, F. Neri, C. Di Bella, M. Di Bello, P. Rigotti.

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1

5:30pm-7:30pm: Outcome of Living-Donor Kidney Transplantation in Cross-Match-Positive Recipients at a Single Center.

D. Okada,¹ M. Okumi,¹ K. Unagami,² T. Shimizu,¹ H. Ishida,¹ K. Tanabe.¹

Poster Session A: Clinical Science: Kidney Immunosuppression: Desensitization • Hall D1

5:30pm-7:30pm: Outcomes Following Transplantation for Hepatocellular Carcinoma.

P. Tabrizian, K. Nakazawa, J. Prigoff, M. Schwartz, S. Florman.

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Hall D1

5:30pm-7:30pm: Outcomes of 100 ABO Incompatible Kidney Transplants: A Single US Center Experience.

S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.

Poster Session A: Clinical Science: Kidney Immunosuppression: Desensitization • Hall D1

5:30pm-7:30pm: Outcomes of Deceased Donor Kidney Transplantation in Elderly Recipients Aged 70 Years and Older.

A. Adamusiak,¹ T. Salter,² P. Andrews,² C. Callaghan.¹

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1

5:30pm-7:30pm: Outcomes of Kidney Transplantation Using Deceased Diabetic Donors.

F. Khan,¹ W. Suki,¹ D. Nguyen,² E. Graviss.²

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1

5:30pm-7:30pm: Percentage of CD19⁺ B Cells as a Predictor of Acute Antibody-Mediated Rejection After Administration of Rituximab in ABO-Incompatible Kidney Transplantation.

T. Hirose, D. Iwami, K. Hotta, H. Sasaki, H. Higuchi, N. Shinohara.

Poster Session A: Clinical Science: Kidney Immunosuppression: Desensitization • Hall D1

5:30pm-7:30pm: Pharmakokinetics of Daclatasvir, Sofosbuvir and GS-331007 in a Prospective Cohort of HCV Positive Kidney Transplant Recipients.

E. Schrezenmeier,¹ P. Galander,¹ F. Hoffmann,² C. Jaeger,² J. Lisec,² J. Schrezenmeier,² O. Staeck,¹ L. Lehner,¹ D. Khadzhynov,¹ F. Halleck,¹ M. Duerr,¹ K. Budde.¹

Poster Session A: Viral Conundrums • Hall D1

5:30pm-7:30pm: Plasma Extracellular Vesicles MicroRNA Signatures Associate with Graft Function Recovery Post-Acute Renal Allograft Injury.

V. Bontha, A. Fernandez-Pineros, D. Bagchi, D. Maluf, E. Rhone, V. Mas.

Poster Session A: Diagnostics/Biomarkers Session I • Hall D1